期刊论文

Clinical and Experimental Research Progress of Wulingsan in Treatment of Renal Diseases:A Review

Cai, T.-R.

中文

中国实验方剂学杂志

1005-9903

2021

27

13

199-206

10.13422/j.cnki.syfjx.20211391

湖南省中医药科研计划项目（2016037）；

本校为第一且通讯机构

五苓散出自张仲景的《伤寒论》,是治疗膀胱气化不利之蓄水证的经典方剂,常被古今医家加减化裁用于治疗肾系疾病,疗效显著,不良反应少。笔者系统检索中国知网,万方数据知识服务平台,PubMed等数据库国内外学者近年来公开发表的关于五苓散治疗肾系疾病的临床应用及药理机制研究文献,通过总结发现,五苓散广泛运用于肾性水肿、糖尿病并发肾病、急慢性肾小球肾炎及肾病综合征、肾功能不全、小便异常等肾系疾病的治疗,并获得良好疗效,无论与西药联用还是单独运用,临床效果均明显优于单纯西药治疗。而药理机制方面,除韩国学者部分报道外,国内学者则呈现团队研究态势,各团队经多年研究发现,五苓散散剂利水...

Wulingsan，a classic prescription first recorded in the Treatise on Cold Damage（Shang Han Lun） by ZHANG Zhong-jing for patients with water retention syndrome due to the disturbance of Qi transformation in bladder，has often been modified by ancient and modern doctors for the treatment of renal diseases. It produced satisfactory outcomes without inducing adverse reactions. The databases including China National Knowledge Infrastructure（CNKI），Wanfang Data Knowledge Service Platform，and PubMed were searched for articles concerning the clinic...